课题基金 / 基金详情

Molecular analysis of the abnormal expression of CD 154 in T cells as a mechanism of induction of autoinimune disease.

Molecular analysis of the abnormal expression of CD 154 in T cells as a mechanism of induction of autoinimune disease.
T 细胞中 CD 154 异常表达作为诱导自身免疫性疾病机制的分子分析。
批准号:
14570431
负责人:
HIROHATA Shunsei
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

HIROHATA Shunsei的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Like IL-12, IFN-α has been found to play an important role in human Th1 responses. Whereas IL-12 enhances CD154 expression on human T cells, the effect of IFN-α has not been elucidated. The present study examined the effects of IFN-α on CD154 expression in human CD4+ T cells, with special attention to the relationship with Th1 responses. IFN-α suppressed CD154 protein and mRNA expression in CD4+ T cells at the initial phase of activation with immobilized anti-CD3, but thereafter enhanced it irrespective of the presence of IL-12. By contrast, IFN-α by itself did not enhance IFN-γ production or mRNA expression in CD4+ T cells in the absence of IL-12, whereas it enhanced it in the presence of IL-12. Either IFN-α or IL-12 did not influence the stability of CD154 mRNA in anti-CD3 activated CD4+ T cells. Rather luciferase assays using a reporter vector containing the CD154 promoter region demonstrate that both IFN-α and IL-12 upregulate the transcription of CD154 mRNA. These results indicate that IFN-α directly enhances CD154 expression in CD4+ T cells by up-regulating the transcription of CD154 mRNA independently of the induction of IFN-γ mRNA expression. The data also suggest that the optimal induction of human Th1 responses by IFN-α might require the presence of IL-12.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
Iwai M, et al.: "Autoimmune hepatitis in a patient with systemic lupus erythematosus."Clin Rheumatol. 22. 234-236 (2003)
Iwai M 等人:“系统性红斑狼疮患者的自身免疫性肝炎。”Clin Rheumatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takayanagi M, et al.: "Myocardial infarction caused by rheumatoid vasculitis : histological evidence of the involvement of T lymphocytes."Rheumatol Int. 23. 315-318 (2003)
Takayanagi M 等人:“类风湿性血管炎引起的心肌梗塞:T 淋巴细胞参与的组织学证据。”Rheumatol Int。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shibuya H, et al.: "Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-α."Clin Exp Immunol. 132. 216-224 (2003)
Shibuya H 等人:“IFN-α 对人 CD4+ T 细胞中 Th1 反应和 CD154 表达的差异调节”。Clin Exp Immunol. 132. 216-224 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Iwaki-Egawa S, et al.: "High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen."J Rheumatol. 31. 17-22 (2004)
Iwaki-Ekawa S 等人:“使用人红细胞钙蛋白酶抑制剂作为抗原,通过 ELISA 检测,抗钙蛋白酶抑制剂自身抗体对类风湿性关节炎具有较高的诊断价值。”J Rheumatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
9
    Analysis of the mechanism of production of pathologic autoantibodies
    • 批准号:
      23591447
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    Analysis of anti-neuronal antibodies in neuropsychiatric systemic lupus erythematosu
    • 批准号:
      20591175
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    Investigation into the roles of autoantibodies in the pathogenesis of central nervous system lupus erythematosus.
    • 批准号:
      12670438
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    Analysis of the molecular machaism of defective T cell functions in reqularing B cell activation in various autoimmune diseases
    • 批准号:
      10670428
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1998
    • 负责人:
      HIROHATA Shunsei
    • 依托单位:
    国内基金
    海外基金
    外泌体ORM1作为肿瘤免疫微环境中T细胞耗竭(T Cell Exhaustion)生物标志物及其功能研究
    • 批准号:
      82102500
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      杨阳
    • 依托单位:
    外泌体ORM1作为肿瘤免疫微环境中T细胞耗竭(T Cell Exhaustion)生物标志物及其功能研究